When developing new drugs, one thing is particularly important: finding and producing the right molecules that can be used as ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

Somewhere between the gua sha movement and the red light therapy craze, vibration plates became the new it girl wellness hack ...

The findings strengthen the case that regeneration is an old trait, offering insights into how complex tissues rebuild themselves.

At the same time, a current of cold electrons travels toward the heated plasma from the opposite direction. When the two meet, the plasma develops filament-shaped instabilities that SLAC’s facilities ...

The Internet History Initiative wants future historians to have a chance to understand how human progress and technical progress align ...

Harnessing the power of the sun holds the promise of providing future societies with energy abundance. To make this a reality, fusion researchers need to address many technological challenges. For ...

Anathalie Mukamanzi never imagined that a routine health campaign would save her life. For more than four months, the 50-year-old mother of five had lived with persistent lower abdominal pain and ...

Cancer treatment facilities in the city are set to receive a boost, as Kalyan Singh Super Specialty Cancer Institute was allocated about Rs326 crore i.

The combined capital and revenue outlay of ₹2,246 crore reflects a dual focus: building world-class infrastructure while ensuring accessible and free care for vulnerable sections of society,” said ...

Inertia Enterprises, the commercial fusion energy company, today announced a new $450 million investment to bring limitless cl ...